InvestorsHub Logo
Followers 119
Posts 7889
Boards Moderated 0
Alias Born 09/02/2011

Re: None

Monday, 03/20/2017 1:27:41 PM

Monday, March 20, 2017 1:27:41 PM

Post# of 73619
Why is no one talking about this?!? This is HUGE!!

The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.

Canopy Growth (TSX:WEED)
OrganiGram (TSXV:OGI)
THC Biomed Intl Ltd (CSNX:THC)
Maple Leaf Green World (TSXV:MGW)
Emerald Health Therapeutics (TSXV:EMH)
Tetra Bio-Pharma (CSNX:TBP)
PharmaCan Capital (TSXV:MJN)
Aphria (TSXV:APH)
Aurora Cannabis (CSNX:ACB)
Cannabix Technologies (CSNX:BLO)
Supreme Pharmaceuticals (CSNX:SL)
Mettrum Health (TSXV:MT)
MYM Nutraceuticals (CSE:MYM)
CannaRoyalty (CSE:CRZ)
Emblem (TSXV:EMC)
Liberty Leaf (CSE:LIB)
Valens GroWorks (CSE:VGW)
Marapharm Ventures (CSE:MDM)
Wildflower Marijuana (CSE:SUN)
True Leaf Pet (CSE:MJ)
Puf Ventures (CSE:PUF)
Cannabix (CSE:BLO)